Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials. magna-neurologica [Internet]. 2025 Jul. 1 [cited 2026 Apr. 2];3(2):138-49. Available from: https://journal.uns.ac.id/index.php/magna-neurologica/article/view/1929